# RIFABUTIN
> **ANDA212430** · Abbreviated New Drug Application (Generic) · Sponsor: I3 PHARMS · Approved 2026-03-19
## Drug
- **FDA Application Number:** ANDA212430
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIFABUTIN
- **Generic name:** RIFABUTIN
- **Active ingredients:** RIFABUTIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** I3 PHARMS
- **Manufacturer:** i3 Pharmaceuticals, LLC
- **First approval:** 2026-03-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212430)
---
*MORVS · CC0 1.0*